USPTO 2015–2025 USPTO PatentsView US Corporation

Angiodynamics, Inc.

USPTO PatentsView assignee record - 147 granted patents across 16 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

147

Total patents granted

CPC technology areas

14.3

Avg claims per patent

-31%

5-year filing velocity

The verdict

Angiodynamics holds 147 US patents across 16 technology areas, rank #2,636 of 50,000 tracked assignees.

#2,636
of 50,000 US assignees by volume: Top 28%
by Innovation Score (43.5/100): 14.3
avg claims per patent: -31%
filing velocity, last 5 yrs

Portfolio overview

Angiodynamics, Inc. has been granted 147 US utility patents between 2015 and 2025, placing Angiodynamics, Inc. at rank #2,636 across all assignees tracked by PlainPatent. This portfolio spans 16 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.3 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Angiodynamics, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Angiodynamics sits between Ocient Holdings Llc (148 patents, rank #2,632) and Hitachi Vantara, Ltd. (147 patents, rank #2,640) - the closest US assignees by grant volume. The composite Innovation Score of 43.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 60 grants, compared with 87 in the 2015–2019 window, a -31% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Angiodynamics, Inc.'s 14.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 16 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Angiodynamics, Inc. against peers pursuing similar technology classes.

Ocient Holdings

148
The University Of…

148
ZF Automotive Ger…

148
Aircelle

147
Blue Yonder Group

147
Cleversafe

147
Giesecke+Devrient…

147
Hitachi Vantara

147
Angiodynamics ◀

147

What this shows Angiodynamics holds 147 patents at rank #2,636, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Angiodynamics

By rank, the assignees closest to #2,636 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Angiodynamics's primary technology class.

Angiodynamics's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

43 Top 28% higher than 72% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Angiodynamics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	18	12.2%
2016	16	10.9%
2017	15	10.2%
2018	21	14.3%
2019	17	11.6%
2020	19	12.9%
2021	8	5.4%
2022	5	3.4%
2023	8	5.4%
2024	10	6.8%
2025	10	6.8%

Which technologies does Angiodynamics, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 84

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 66

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 22

F16K - VALVES; TAPS; COCKS; ACTUATING-FLOATS; DEVICES FOR VENTING OR AERATING 9

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 7

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 6

C08L - COMPOSITIONS OF MACROMOLECULAR COMPOUNDS 4

G02B - OPTICAL ELEMENTS, SYSTEMS OR APPARATUS 3

G01T - MEASUREMENT OF NUCLEAR OR X-RADIATION 3

C08G - MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS 2

C09D - COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR 2

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 2

B29L - INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES 1

B29C - SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING 1

G06T - IMAGE DATA PROCESSING OR GENERATION, IN GENERAL 1

Top 15 of 16 technology areas

Patent Moat Analysis

Portfolio Volume Moderate

Tech Breadth Focused

Claim Depth Standard

Velocity Declining

Where it ranks

Overall rank by patents

#2,636

Across all tracked assignees

Innovation Score

43.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Angiodynamics, Inc. hold?

Angiodynamics, Inc. holds 147 US granted patents filed between 2015 and 2025, spanning 16 technology areas.

What is Angiodynamics, Inc.'s Innovation Score?

Angiodynamics, Inc. has an Innovation Score of 43.5 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Angiodynamics, Inc. focus on?

Angiodynamics, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 84 patents. The company has filed patents in 16 CPC subclasses total.

Is Angiodynamics, Inc.'s patent filing rate increasing or decreasing?

Angiodynamics, Inc.'s recent filing velocity is -31% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for Angiodynamics, Inc.'s patents?

Angiodynamics, Inc.'s patents average 14.3 claims each. This falls within the standard range, providing solid legal coverage.

How is the Angiodynamics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Angiodynamics's 147 grants land it in the top 28% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Angiodynamics ranks #2,636 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61B - see who else leads that technology area. A61B leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.